Cell and Gene Outsourcing
-
A Deeper Look At What's Driving Dependence On Biotech Contract Manufacturers
4/19/2024
Are you struggling to find CDMO capacity? Here are some of the drivers behind the contract manufacturing market's exponential growth.
-
Clinical Research As A Delicate Ecosystem
4/18/2024
Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing essential support and resources that empower it to thrive in its objectives and endeavors.
-
A Rentschler Collaboration Story
4/17/2024
Learn how a collaboration between Cytiva and Rentschler Biopharma facilitates the efficient and flexible production of viral vectors.
-
Protein Characterization And Biosafety Testing Services
4/8/2024
Discover a partner with extensive expert knowledge to support your new biological entity (NBE) or biosimilar with off-the-shelf and custom assays, as well as regulatory-compliant biosafety testing.
-
Comprehensive Media Solutions For Your Protein-Based Therapies
4/8/2024
Explore a comprehensive offering of CHO cell culture media and companion feeds as well as advanced cell line development and supporting media services that enhances clone selection and titer production.
-
Strategic Management Of The Mature Product Portfolio
4/7/2024
Explore a new outsourcing paradigm that integrates expertise, regulatory knowledge, efficiency, and cost containment, moving beyond traditional low-cost offshore staffing models.
-
Converting iPSC To T Cells: Key Challenges And Considerations
3/27/2024
Explore how by addressing challenges in differentiation, clone selection, and manufacturing, iPSC-based T cell therapies could revolutionize cancer treatment and other diseases.
-
Gain Support For Your Regulatory Submission Process
3/27/2024
Join us in this video as we delve into invaluable tips, cutting-edge tools, and unwavering support that Cytiva offers to facilitate your documentation progress.
-
An Inside Look At Cell Therapy Services And Support
3/25/2024
“Services” and “support.” What do those words mean in the life science manufacturing industry? The truth is, they’re quite subjective—and relative to each company. Here’s how we define services and support at Cytiva.
-
De-Risking Drug Development With Organ-On-A-Chip Contract Research Services
3/25/2024
Delve into Emulate's variety of Organ-on-a-Chip services and tailored study design, supported by data-driven case studies showcasing its collaboration's impact on pharmaceutical decision-making.